| Drug Name | ( Forxiga® ( Dapagliflozin |
|---|---|
| Drug Class |
Anti-diabetic
|
| Risk minimization type |
Healthcare provider guide
patient guide
Safety communication
|
| Specialty (Theraputic area) |
Endocrine
|
| Risk |
Risk of diabetic ketoacidosis Risk of Rare but Serious Infection in the Genital Area with Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Risk of Fournier’s gangrene (necrotising fasciitis of the perineum)
|
| patient guide |
|
| safety communication |
|
| Dear Healthcare provider letter DHPC |
|